TME-SW
01698
XIAOMI-W
01810
TRIP.COM-S
09961
BIDU-SW
09888
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.34%1.41B | 10.94%2.69B | 4.45%1.33B | 13.53%2.42B | 25.11%1.28B | 15.33%2.13B | 18.70%1.02B | -30.60%1.85B | -17.94%860.25M | -2.35%2.67B |
Operating income | 5.34%1.41B | 10.94%2.69B | 4.45%1.33B | 13.53%2.42B | 25.11%1.28B | 15.33%2.13B | 18.70%1.02B | -30.60%1.85B | -17.94%860.25M | -2.35%2.67B |
Cost of sales | -10.38%-1.06B | -11.03%-1.99B | -2.97%-961.06M | -13.30%-1.79B | -25.43%-933.36M | -3.51%-1.58B | -21.17%-744.11M | 29.32%-1.53B | 37.73%-614.11M | 15.63%-2.16B |
Operating expenses | -10.38%-1.06B | -11.03%-1.99B | -2.97%-961.06M | -13.30%-1.79B | -25.43%-933.36M | -3.51%-1.58B | -21.17%-744.11M | 29.32%-1.53B | 37.73%-614.11M | 15.63%-2.16B |
Gross profit | -7.63%344.73M | 10.67%695.22M | 8.47%373.21M | 14.21%628.18M | 24.22%344.09M | 71.83%550.01M | 12.53%276.99M | -36.16%320.1M | 296.20%246.14M | 204.69%501.4M |
Selling expenses | -9.78%-53.87M | -4.70%-101.85M | 0.28%-49.07M | -2.53%-97.28M | -9.76%-49.2M | -7.05%-94.88M | -2.07%-44.83M | 3.02%-88.63M | -2,241.20%-43.92M | -3,782.46%-91.39M |
Administrative expenses | 0.60%-58.91M | 10.15%-126.21M | 7.20%-59.26M | -5.74%-140.46M | -20.50%-63.86M | -0.82%-132.84M | 32.09%-53M | 13.68%-131.75M | -49.94%-78.04M | -423.15%-152.64M |
Revaluation surplus | ---- | -468.73%-108.28M | ---- | -60.94%-19.04M | ---- | 93.96%-11.83M | ---- | -28.52%-195.71M | ---- | ---152.28M |
-Changes in the fair value of investment property | ---- | -468.73%-108.28M | ---- | -60.94%-19.04M | ---- | 93.96%-11.83M | ---- | -28.52%-195.71M | ---- | ---152.28M |
Impairment and provision | ---- | -270.70%-70.66M | ---- | -375.22%-19.06M | ---- | 99.82%-4.01M | ---- | -508.36%-2.26B | ---- | ---372.05M |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---59.82M |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.94%-396.46M | ---- | ---283.3M |
-Other impairment is provision | ---- | -270.70%-70.66M | ---- | -375.22%-19.06M | ---- | 99.79%-4.01M | ---- | -6,354.93%-1.87B | ---- | ---28.92M |
Special items of operating profit | -93.55%9.22M | 620.46%156.33M | 1,635.92%142.92M | -45.01%21.7M | -82.35%8.23M | 78.70%39.46M | 268.87%46.65M | -92.11%22.08M | 621.45%12.65M | 799,254.29%279.7M |
Operating profit | -40.86%241.17M | 18.85%444.56M | 70.45%407.8M | 8.13%374.05M | 5.95%239.25M | 114.80%345.92M | 65.04%225.82M | -18,440.16%-2.34B | 1,274.57%136.83M | -90.42%12.74M |
Financing cost | 24.61%-14.6M | 20.30%-37.05M | 27.67%-19.36M | 7.37%-46.49M | 30.92%-26.77M | 70.65%-50.19M | 59.22%-38.75M | -8.64%-171.01M | -466.45%-95.03M | -289.80%-157.42M |
Special items of earning before tax | -1,032.74%-288.54M | ---- | -290.75%-25.47M | ---- | 33.89%-6.52M | ---- | 95.73%-9.86M | ---- | -387.79%-230.92M | ---- |
Earning before tax | -117.07%-61.98M | 24.41%407.51M | 76.23%362.97M | 10.76%327.56M | 16.23%205.96M | 111.79%295.73M | 193.70%177.2M | -1,633.77%-2.51B | -357.61%-189.13M | -167.00%-144.67M |
Tax | 151.22%35.74M | -42.68%-82.46M | -87.59%-69.77M | 1.22%-57.79M | -448.84%-37.2M | -36.99%-58.51M | 65.98%-6.78M | -336.43%-42.71M | -90.56%-19.92M | 74.86%-9.79M |
After-tax profit from continuing operations | -108.95%-26.23M | 20.49%325.05M | 73.73%293.19M | 13.72%269.76M | -0.97%168.77M | 109.30%237.22M | 181.52%170.42M | -1,551.58%-2.55B | -432.03%-209.05M | -187.26%-154.46M |
After-tax profit from non-continuing business | ---- | ---- | ---- | 432.21%2.07B | 2,612.72%2.07B | ---622.41M | ---82.29M | ---- | ---- | ---- |
Earning after tax | -108.95%-26.23M | -86.09%325.05M | -86.89%293.19M | 706.84%2.34B | 2,437.59%2.24B | 84.90%-385.19M | 142.16%88.13M | -1,551.58%-2.55B | -304.18%-209.05M | -173.31%-154.46M |
Profit attributable to shareholders | -108.95%-26.23M | -86.09%325.05M | -86.89%293.19M | 706.84%2.34B | 2,437.59%2.24B | 84.90%-385.19M | 142.16%88.13M | -1,551.58%-2.55B | -304.18%-209.05M | -173.31%-154.46M |
Basic earnings per share | -108.33%-0.003 | -86.10%0.0404 | -87.05%0.036 | 706.68%0.2906 | 2,427.27%0.278 | 84.89%-0.0479 | 142.31%0.011 | -1,517.86%-0.3171 | -295.49%-0.026 | -170.25%-0.0196 |
Diluted earnings per share | -108.33%-0.003 | -86.10%0.0404 | -87.05%0.036 | 706.68%0.2906 | 2,427.27%0.278 | 84.89%-0.0479 | 142.31%0.011 | -1,517.86%-0.3171 | -295.49%-0.026 | -217.37%-0.0196 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.